The origins of the Clinical Pharmacy Program at the University of California, San Francisco.
نویسندگان
چکیده
submitted the column to DlCP. Don Francke, without any hesitation (at least from our vantage point), accepted our proposal and the column was initiated. . We were in for a few surprises, not the least of which was the constant pressure of monthly deadlines . We really Wlderestimated the time commiunent. As a consequence, much of the preparation was done after hours. Another \\13S the quick and enthusiastic feedback ~ got from readers of the column, which ruBy helped to keep us motivated. I also remember the effect that it had on students and resi dents. The potential for participation seemed to energize many of them. The fact that the column continues to be published reg ularly more than 20 years later seems to confirm the validity of the original concept. The concept also has not been fun damentally changed by successive colwnn editors, a testi mony to their collective wisdom not to ftx what is not bro ken. The significanct': of the column's longevity probably lies in the fact that it has reported real experiences that can be embrnced as such by the readers and has never Cried to be anything else. The hard way to learn anything is through one's own experience. It is easier to learn from somebody else's experience. I think that is the enduring appeal of "DIAS Rounds."
منابع مشابه
Low Molecular Weight Heparin Overdose: A 10 Year Case Series
Background: Low molecular weight heparin (LMWH) is used for the treatment and prevention of coagulative disorders. Few patients receiving therapeutic doses of LMWH develop major hemorrhage. Currently there are few reports in the literature on acute overdose on adults. In this study, clinical profile, treatment and outcome of 21 patients who acutely overdosed enoxaparin are described. Method...
متن کامل"Whose job is it, really?" Physicians', nurses', and pharmacists' perspectives on completing inpatient medication reconciliation.
Department of Clinical Pharmacy, School of Pharmacy, University of California, San Francisco, San Francisco, California; Department of Medicine, School of Medicine, University of California, San Francisco, San Francisco, California; School of Public Health and Health Systems, University of Waterloo, Waterloo, Ontario, Canada; Department of Epidemiology and Biostatistics, University of Californi...
متن کامل727Evaluating the Impact of Socioeconomic Status on Clinical Presentation in Patients with Staphylococcus aureus Bacteremia
Presentation in Patients with Staphylococcus aureus Bacteremia Angelo Clemenzi-Allen, MD; Sanjiv Baxi, MS, MD, MPH; Alice Gahbauer, PharmD; Brandon Imp; Daniel Deck, PharmD; Sarah Doernberg, MD; Henry F. Chambers, MD; Medicine, University of California San Francisco, San Francisco, CA; University of Michigan Health System, Ann Arbor, MI; Pharmacy, University of Pittsburgh, Pittsburgh, PA; Medic...
متن کامل724Vancomycin Minimum Inhibitory Concentration Does Not Predict Death, Recurrence or Readmission in Patients with Staphylococcus aureus Bacteremia in a Safety-Net Hospital
Death, Recurrence or Readmission in Patients with Staphylococcus aureus Bacteremia in a Safety-Net Hospital Sanjiv Baxi, MS, MD, MPH; Angelo Clemenzi-Allen, MD; Alice Gahbauer, PharmD; Daniel Deck, PharmD; Brandon Imp, Medicine; Sarah Doernberg, MD; Henry F. Chambers, MD; Medicine, University of California San Francisco, San Francisco, CA; Pharmacy, University of Pittsburgh, Pittsburgh, PA; Dep...
متن کاملAchieving a “Grand Convergence” in Global Health by 2035: Rwanda Shows the Way; Comment on “Improving the World’s Health Through the Post-2015 Development Agenda: Perspectives From Rwanda”
Global Health 2035, the report of The Lancet Commission on Investing in Health, laid out a bold, highly ambitious framework for making rapid progress in improving global public health outcomes. It showed that with the right health investments, the international community could achieve a “grand convergence” in global health—a reduction in avertable infectious, maternal, and child deaths down to ...
متن کاملA Patient with Interstitial 5q21 Deletion, Familial Adenomatous Polyposis, Dysmorphic Features, and Profound Neurologic Dysfunction
Familial adenomatous polyposis (FAP) is a hereditary autosomal dominant cancer syndrome, results from germ line mutation or deletion of the Adenomatous Polyposis Coli (APC) gene on chromosome 5q21. Patients with FAP suffer from multiple polyps mainly at the colorectal region as well as other parts of the gastrointestinal tract, which has propensity to transform into carcinoma. FAP has also...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- DICP : the annals of pharmacotherapy
دوره 25 3 شماره
صفحات -
تاریخ انتشار 1991